ARGS
Argos Therapeutics, Inc.
ARGS
ARGS
Delisted
ARGS was delisted on the 24th of April, 2018.
52 hedge funds and large institutions have $102M invested in Argos Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 9 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% more funds holding
Funds holding: 46 → 52 (+6)
Holders
52
Holding in Top 10
1
Calls
$28.6M
Puts
$203K
Top Buyers
| 1 | +$5.02M | |
| 2 | +$586K | |
| 3 | +$465K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$295K |
| 5 |
SMH
Sanders Morris Harris
Houston,
Texas
|
+$250K |
Top Sellers
| 1 | -$554K | |
| 2 | -$501K | |
| 3 | -$125K | |
| 4 |
DTL
Dynamic Technology Lab
Singapore
|
-$94K |
| 5 |
Goldman Sachs
New York
|
-$67.8K |